000269189 001__ 269189
000269189 005__ 20240808164458.0
000269189 0247_ $$2doi$$a10.1016/S1474-4422(24)00083-8
000269189 0247_ $$2pmid$$apmid:38631765
000269189 0247_ $$2ISSN$$a1474-4422
000269189 0247_ $$2ISSN$$a1474-4465
000269189 0247_ $$2altmetric$$aaltmetric:162535398
000269189 037__ $$aDZNE-2024-00488
000269189 041__ $$aEnglish
000269189 082__ $$a610
000269189 1001_ $$aValentino, Rebecca R$$b0
000269189 245__ $$aMAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
000269189 260__ $$aLondon$$bLancet Publ. Group$$c2024
000269189 3367_ $$2DRIVER$$aarticle
000269189 3367_ $$2DataCite$$aOutput Types/Journal article
000269189 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1713865981_10932
000269189 3367_ $$2BibTeX$$aARTICLE
000269189 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000269189 3367_ $$00$$2EndNote$$aJournal Article
000269189 520__ $$aPick's disease is a rare and predominantly sporadic form of frontotemporal dementia that is classified as a primary tauopathy. Pick's disease is pathologically defined by the presence in the frontal and temporal lobes of Pick bodies, composed of hyperphosphorylated, three-repeat tau protein, encoded by the MAPT gene. MAPT has two distinct haplotypes, H1 and H2; the MAPT H1 haplotype is the major genetic risk factor for four-repeat tauopathies (eg, progressive supranuclear palsy and corticobasal degeneration), and the MAPT H2 haplotype is protective for these disorders. The primary aim of this study was to evaluate the association of MAPT H2 with Pick's disease risk, age at onset, and disease duration.In this genetic association study, we used data from the Pick's disease International Consortium, which we established to enable collection of data from individuals with pathologically confirmed Pick's disease worldwide. For this analysis, we collected brain samples from individuals with pathologically confirmed Pick's disease from 35 sites (brainbanks and hospitals) in North America, Europe, and Australia between Jan 1, 2020, and Jan 31, 2023. Neurologically healthy controls were recruited from the Mayo Clinic (FL, USA, or MN, USA between March 1, 1998, and Sept 1, 2019). For the primary analysis, individuals were directly genotyped for the MAPT H1-H2 haplotype-defining variant rs8070723. In a secondary analysis, we genotyped and constructed the six-variant-defined (rs1467967-rs242557-rs3785883-rs2471738-rs8070723-rs7521) MAPT H1 subhaplotypes. Associations of MAPT variants and MAPT haplotypes with Pick's disease risk, age at onset, and disease duration were examined using logistic and linear regression models; odds ratios (ORs) and β coefficients were estimated and correspond to each additional minor allele or each additional copy of the given haplotype.We obtained brain samples from 338 people with pathologically confirmed Pick's disease (205 [61%] male and 133 [39%] female; 338 [100%] White) and 1312 neurologically healthy controls (611 [47%] male and 701 [53%] female; 1312 [100%] White). The MAPT H2 haplotype was associated with increased risk of Pick's disease compared with the H1 haplotype (OR 1·35 [95% CI 1·12 to 1·64], p=0·0021). MAPT H2 was not associated with age at onset (β -0·54 [95% CI -1·94 to 0·87], p=0·45) or disease duration (β 0·05 [-0·06 to 0·16], p=0·35). Although not significant after correcting for multiple testing, associations were observed at p less than 0·05: with risk of Pick's disease for the H1f subhaplotype (OR 0·11 [0·01 to 0·99], p=0·049); with age at onset for H1b (β 2·66 [0·63 to 4·70], p=0·011), H1i (β -3·66 [-6·83 to -0·48], p=0·025), and H1u (β -5·25 [-10·42 to -0·07], p=0·048); and with disease duration for H1x (β -0·57 [-1·07 to -0·07], p=0·026).The Pick's disease International Consortium provides an opportunity to do large studies to enhance our understanding of the pathobiology of Pick's disease. This study shows that, in contrast to the decreased risk of four-repeat tauopathies, the MAPT H2 haplotype is associated with an increased risk of Pick's disease in people of European ancestry. This finding could inform development of isoform-related therapeutics for tauopathies.Wellcome Trust, Rotha Abraham Trust, Brain Research UK, the Dolby Fund, Dementia Research Institute (Medical Research Council), US National Institutes of Health, and the Mayo Clinic Foundation.
000269189 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000269189 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000269189 650_2 $$2MeSH$$aFemale
000269189 650_2 $$2MeSH$$aHumans
000269189 650_2 $$2MeSH$$aMale
000269189 650_2 $$2MeSH$$aGenetic Association Studies
000269189 650_2 $$2MeSH$$aHaplotypes
000269189 650_2 $$2MeSH$$aPick Disease of the Brain: genetics
000269189 650_2 $$2MeSH$$atau Proteins: genetics
000269189 650_2 $$2MeSH$$aTauopathies
000269189 650_7 $$2NLM Chemicals$$aMAPT protein, human
000269189 7001_ $$aScotton, William J$$b1
000269189 7001_ $$aRoemer, Shanu F$$b2
000269189 7001_ $$aLashley, Tammaryn$$b3
000269189 7001_ $$aHeckman, Michael G$$b4
000269189 7001_ $$aShoai, Maryam$$b5
000269189 7001_ $$aMartinez-Carrasco, Alejandro$$b6
000269189 7001_ $$aTamvaka, Nicole$$b7
000269189 7001_ $$aWalton, Ronald L$$b8
000269189 7001_ $$aBaker, Matthew C$$b9
000269189 7001_ $$aMacpherson, Hannah L$$b10
000269189 7001_ $$aReal, Raquel$$b11
000269189 7001_ $$aSoto-Beasley, Alexandra I$$b12
000269189 7001_ $$aMok, Kin$$b13
000269189 7001_ $$aRevesz, Tamas$$b14
000269189 7001_ $$aChristopher, Elizabeth A$$b15
000269189 7001_ $$aDeTure, Michael$$b16
000269189 7001_ $$aSeeley, William W$$b17
000269189 7001_ $$aLee, Edward B$$b18
000269189 7001_ $$aFrosch, Matthew P$$b19
000269189 7001_ $$aMolina-Porcel, Laura$$b20
000269189 7001_ $$aGefen, Tamar$$b21
000269189 7001_ $$aRedding-Ochoa, Javier$$b22
000269189 7001_ $$aGhetti, Bernardino$$b23
000269189 7001_ $$aRobinson, Andrew C$$b24
000269189 7001_ $$aKobylecki, Christopher$$b25
000269189 7001_ $$aRowe, James B$$b26
000269189 7001_ $$aBeach, Thomas G$$b27
000269189 7001_ $$aTeich, Andrew F$$b28
000269189 7001_ $$aKeith, Julia L$$b29
000269189 7001_ $$aBodi, Istvan$$b30
000269189 7001_ $$aHalliday, Glenda M$$b31
000269189 7001_ $$aGearing, Marla$$b32
000269189 7001_ $$0P:(DE-2719)2811333$$aArzberger, Thomas$$b33$$udzne
000269189 7001_ $$aMorris, Christopher M$$b34
000269189 7001_ $$aWhite, Charles L$$b35
000269189 7001_ $$aMechawar, Naguib$$b36
000269189 7001_ $$aBoluda, Susana$$b37
000269189 7001_ $$0P:(DE-2719)9000939$$aMacKenzie, Ian R$$b38
000269189 7001_ $$aMcLean, Catriona$$b39
000269189 7001_ $$aCykowski, Matthew D$$b40
000269189 7001_ $$aWang, Shih-Hsiu J$$b41
000269189 7001_ $$aGraff, Caroline$$b42
000269189 7001_ $$aNagra, Rashed M$$b43
000269189 7001_ $$aKovacs, Gabor G$$b44
000269189 7001_ $$aGiaccone, Giorgio$$b45
000269189 7001_ $$0P:(DE-2719)2810592$$aNeumann, Manuela$$b46$$udzne
000269189 7001_ $$aAng, Lee-Cyn$$b47
000269189 7001_ $$aCarvalho, Agostinho$$b48
000269189 7001_ $$aMorris, Huw R$$b49
000269189 7001_ $$aRademakers, Rosa$$b50
000269189 7001_ $$aHardy, John A$$b51
000269189 7001_ $$aDickson, Dennis W$$b52
000269189 7001_ $$aRohrer, Jonathan D$$b53
000269189 7001_ $$aRoss, Owen A$$b54
000269189 7001_ $$aConsortium, Pick's disease International$$b55$$eCollaboration Author
000269189 7001_ $$aWarner, Thomas T$$b56$$eContributor
000269189 7001_ $$aJaunmuktane, Zane$$b57$$eContributor
000269189 7001_ $$aBoeve, Bradley F$$b58$$eContributor
000269189 7001_ $$aDuara, Ranjan$$b59$$eContributor
000269189 7001_ $$aGraff-Radford, Neill R$$b60$$eContributor
000269189 7001_ $$aJosephs, Keith A$$b61$$eContributor
000269189 7001_ $$aKnopman, David S$$b62$$eContributor
000269189 7001_ $$aKoga, Shunsuke$$b63$$eContributor
000269189 7001_ $$aMurray, Melissa E$$b64$$eContributor
000269189 7001_ $$aLyons, Kelly E$$b65$$eContributor
000269189 7001_ $$aPahwa, Rajesh$$b66$$eContributor
000269189 7001_ $$aPetersen, Ronald C$$b67$$eContributor
000269189 7001_ $$aWhitwell, Jennifer L$$b68$$eContributor
000269189 7001_ $$aGrinberg, Lea T$$b69$$eContributor
000269189 7001_ $$aMiller, Bruce$$b70$$eContributor
000269189 7001_ $$aSchlereth, Athena$$b71$$eContributor
000269189 7001_ $$aSpina, Salvatore$$b72$$eContributor
000269189 7001_ $$aGrossman, Murray$$b73$$eContributor
000269189 7001_ $$aIrwin, David J$$b74$$eContributor
000269189 7001_ $$aSuh, EunRan$$b75$$eContributor
000269189 7001_ $$aTrojanowski, John Q$$b76$$eContributor
000269189 7001_ $$aVan Deerlin, Vivianna M$$b77$$eContributor
000269189 7001_ $$aWolk, David A$$b78$$eContributor
000269189 7001_ $$aConnors, Theresa R$$b79$$eContributor
000269189 7001_ $$aDooley, Patrick M$$b80$$eContributor
000269189 7001_ $$aOakley, Derek H$$b81$$eContributor
000269189 7001_ $$aAldecoa, Iban$$b82$$eContributor
000269189 7001_ $$aBalasa, Mircea$$b83$$eContributor
000269189 7001_ $$aGelpi, Ellen$$b84$$eContributor
000269189 7001_ $$aBorrego-Écija, Sergi$$b85$$eContributor
000269189 7001_ $$aGascon-Bayarri, Jordi$$b86$$eContributor
000269189 7001_ $$aSánchez-Valle, Raquel$$b87$$eContributor
000269189 7001_ $$aSanz-Cartagena, Pilar$$b88$$eContributor
000269189 7001_ $$aPiñol-Ripoll, Gerard$$b89$$eContributor
000269189 7001_ $$aBigio, Eileen H$$b90$$eContributor
000269189 7001_ $$aFlanagan, Margaret E$$b91$$eContributor
000269189 7001_ $$aRogalski, Emily J$$b92$$eContributor
000269189 7001_ $$aWeintraub, Sandra$$b93$$eContributor
000269189 7001_ $$aSchneider, Julie A$$b94$$eContributor
000269189 7001_ $$aPeng, Lihua$$b95$$eContributor
000269189 7001_ $$aZhu, Xiongwei$$b96$$eContributor
000269189 7001_ $$aChang, Koping$$b97$$eContributor
000269189 7001_ $$aTroncoso, Juan C$$b98$$eContributor
000269189 7001_ $$aProkop, Stefan$$b99$$eContributor
000269189 7001_ $$aNewell, Kathy L$$b100$$eContributor
000269189 7001_ $$aJones, Matthew$$b101$$eContributor
000269189 7001_ $$aRichardson, Anna$$b102$$eContributor
000269189 7001_ $$aRoncaroli, Federico$$b103$$eContributor
000269189 7001_ $$aSnowden, Julie$$b104$$eContributor
000269189 7001_ $$aAllinson, Kieren$$b105$$eContributor
000269189 7001_ $$aSingh, Poonam$$b106$$eContributor
000269189 7001_ $$aSerrano, Geidy E$$b107$$eContributor
000269189 7001_ $$aFlowers, Xena E$$b108$$eContributor
000269189 7001_ $$aGoldman, James E$$b109$$eContributor
000269189 7001_ $$aHeaps, Allison C$$b110$$eContributor
000269189 7001_ $$aLeskinen, Sandra P$$b111$$eContributor
000269189 7001_ $$aBlack, Sandra E$$b112$$eContributor
000269189 7001_ $$aMasellis, Mario$$b113$$eContributor
000269189 7001_ $$aKing, Andrew$$b114$$eContributor
000269189 7001_ $$aAl-Sarraj, Safa$$b115$$eContributor
000269189 7001_ $$aTroakes, Claire$$b116$$eContributor
000269189 7001_ $$aHodges, John R$$b117$$eContributor
000269189 7001_ $$aKril, Jillian J$$b118$$eContributor
000269189 7001_ $$aKwok, John B$$b119$$eContributor
000269189 7001_ $$aPiguet, Olivier$$b120$$eContributor
000269189 7001_ $$aRoeber, Sigrun$$b121$$eContributor
000269189 7001_ $$aAttems, Johannes$$b122$$eContributor
000269189 7001_ $$aThomas, Alan J$$b123$$eContributor
000269189 7001_ $$aEvers, Bret M$$b124$$eContributor
000269189 7001_ $$aBieniek, Kevin F$$b125$$eContributor
000269189 7001_ $$aSieben, Anne A$$b126$$eContributor
000269189 7001_ $$aCras, Patrick P$$b127$$eContributor
000269189 7001_ $$aDe Vil, Bart B$$b128$$eContributor
000269189 7001_ $$aBird, Thomas$$b129$$eContributor
000269189 7001_ $$aCastellani, Rudolph J$$b130$$eContributor
000269189 7001_ $$aChaffee, Ann$$b131$$eContributor
000269189 7001_ $$aFranklin, Erin$$b132$$eContributor
000269189 7001_ $$aHaroutunian, Vahram$$b133$$eContributor
000269189 7001_ $$aJacobsen, Max$$b134$$eContributor
000269189 7001_ $$aKeene, Dirk$$b135$$eContributor
000269189 7001_ $$aLatimer, Caitlin S$$b136$$eContributor
000269189 7001_ $$aMetcalf, Jeff$$b137$$eContributor
000269189 7001_ $$aPerrin, Richard J$$b138$$eContributor
000269189 7001_ $$aPurohit, Dushyant P$$b139$$eContributor
000269189 7001_ $$aRissman, Robert A$$b140$$eContributor
000269189 7001_ $$aSchantz, Aimee$$b141$$eContributor
000269189 7001_ $$aWalker, Jamie$$b142$$eContributor
000269189 7001_ $$aDe Deyn, Peter P$$b143$$eContributor
000269189 7001_ $$aDuyckaerts, Charles$$b144$$eContributor
000269189 7001_ $$aLe Ber, Isabelle$$b145$$eContributor
000269189 7001_ $$aSeilhean, Danielle$$b146$$eContributor
000269189 7001_ $$aTurbant-Leclere, Sabrina$$b147$$eContributor
000269189 7001_ $$aErvin, John F$$b148$$eContributor
000269189 7001_ $$aNennesmo, Inger$$b149$$eContributor
000269189 7001_ $$aRiehl, James$$b150$$eContributor
000269189 7001_ $$aNacmias, Benedetta$$b151$$eContributor
000269189 7001_ $$aFinger, Elizabeth C$$b152$$eContributor
000269189 7001_ $$aBlauwendraat, Cornelis$$b153$$eContributor
000269189 7001_ $$aNalls, Mike A$$b154$$eContributor
000269189 7001_ $$aSingleton, Andrew B$$b155$$eContributor
000269189 7001_ $$aVitale, Dan$$b156$$eContributor
000269189 7001_ $$aCunha, Cristina$$b157$$eContributor
000269189 7001_ $$aWszolek, Zbigniew K$$b158$$eContributor
000269189 773__ $$0PERI:(DE-600)2079704-7$$a10.1016/S1474-4422(24)00083-8$$gVol. 23, no. 5, p. 487 - 499$$n5$$p487 - 499$$tThe lancet$$v23$$x1474-4422$$y2024
000269189 8564_ $$uhttps://pub.dzne.de/record/269189/files/DZNE-2024-00488%20SUP.pdf
000269189 8564_ $$uhttps://pub.dzne.de/record/269189/files/DZNE-2024-00488.pdf$$yOpenAccess
000269189 8564_ $$uhttps://pub.dzne.de/record/269189/files/DZNE-2024-00488%20SUP.pdf?subformat=pdfa$$xpdfa
000269189 8564_ $$uhttps://pub.dzne.de/record/269189/files/DZNE-2024-00488.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000269189 909CO $$ooai:pub.dzne.de:269189$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000269189 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2811333$$aExternal Institute$$b33$$kExtern
000269189 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810592$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b46$$kDZNE
000269189 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000269189 9141_ $$y2024
000269189 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000269189 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000269189 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET NEUROL : 2022$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000269189 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)9940$$2StatID$$aIF >= 40$$bLANCET NEUROL : 2022$$d2023-10-24
000269189 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000269189 9201_ $$0I:(DE-2719)1210003$$kAG Neumann$$lMolecular Neuropathology of Neurodegenerative Diseases$$x0
000269189 980__ $$ajournal
000269189 980__ $$aVDB
000269189 980__ $$aUNRESTRICTED
000269189 980__ $$aI:(DE-2719)1210003
000269189 9801_ $$aFullTexts